Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell c...
Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, ...
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )
26 Feb 2021
New tools that can be used in clinical practice to make better decisions for wom...
Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium
New tools that can be used in clinical practice to make better decisions for women with early breast cancer ( Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium )
25 Feb 2021
SEMS trial: result of a prospective, multi-institutional phase II clinical trial...
Dr Sia Daneshmand - University of Southern California, Los Angeles, USA
SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma ( Dr Sia Daneshmand - University of Southern California, Los Angeles, USA )
24 Feb 2021
Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib...
Prof Hope Rugo - University of California San Francisco, San Francisco, USA
Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )
24 Feb 2021
Challenges in nursing GU cancer patients during COVID-19
Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK
Challenges in nursing GU cancer patients during COVID-19 ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )
24 Feb 2021
Latest developments in the treatment of mRCC
Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald
Latest developments in the treatment of mRCC ( Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald )
24 Feb 2021
Long term response to apalutamide and other updates impacting patients with nmCR...
Prof Axel Merseburger and Prof Matthew Smith
Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU 2021 ( Prof Axel Merseburger and Prof Matthew Smith )
22 Feb 2021
mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early t...
Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt A...
mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early treatment? ( Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt Attard )
19 Feb 2021
Re-irradiation in breast cancer
Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
Re-irradiation in breast cancer ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )
19 Feb 2021
Postmastectomy radiation therapy in breast cancer patients who had immediate rec...
Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
Postmastectomy radiation therapy in breast cancer patients who had immediate reconstruction ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )
19 Feb 2021
Current treatment standards for primary ovarian cancer
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Current treatment standards for primary ovarian cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021
Evolving medical treatment in advanced/recurrent endometrial cancer
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Evolving medical treatment in advanced/recurrent endometrial cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021